Biosimilars LatAm – Mexico 2024

The 2024 edition in Mexico aims to provide insights into local and international regulatory matters, explore biobetters and next-generation biologics, discuss the impact of biosimilar licenses on pharmaceutical innovation in Mexico, and delve into the evolving landscape of nearshoring and newshoring strategies in the industry.

Plan Your 1-to-1 Meetings with JackLeckerman App

1. JackLeckerman App: Login & Meeting Notifications

Download the JackLeckerman App and sign up.

Check your email for the login details, or use the “Forgot Password” option to retrieve them.

You will receive meeting reminders on your mobile over the 2 days.

These reminders will include meeting requests, meeting confirmations, and messages from other attendees and the coordinator.

2. Attendee list to Plan Your Meetings

Browse the attendee list and select someone for a 10-minute 1-to-1 Meeting request.

Meeting requests close one hour before each Networking session in the program.

3. Managing Meeting Requests, Your Meetings Schedule

Accept or decline meeting requests through the “Meetings” button.

Check your scheduled meetings for the upcoming networking break.

4. Meeting Point Location in the Coffee Break Area

Go to the coffee break area and find the table number to meet your colleague

Who will
you meet?

More than:

Participants

Companies

HCPs

Patients

Academy

Investors

Institutions

Associations

Service Providers

Government Agencies

Industry Executives from Latam

From these areas:

Biosimilars
Biobetters
Biotechnology
Biotherapeutics
Analytical science
Regulatory compliance
Quality Control
Clinical immunology
Scientific Affairs
Pharmacovigilance
Research
Regulatory
Business Development
Marketing

Program at a Glance

Biosimilar Regulatory Updates

Invited: COFEPRIS

Biobetters and Next-Generation Biologics

Streamlining Biosimilar Approval: MHRA's Approach to Waiving Comparative Efficacy Testing

The Impact of Biosimilar Licenses on Pharmaceutical Innovation in Mexico

Benefits and Challenges of Regulatory Harmonization Efforts in Latin America

AEMPS/FDA Presentation: Latest International Achievements and Developments in Relation to Mexico

Nearshoring is Dead, Long Live Newshoring

Full Programme in the PDF Agenda

Download Agenda

Download Agenda

Speaker Board in 2023

Photo Gallery from Previous Events

Open Gallery

104PHBIBR19-photo-gallery-2018-desktop-01

Testimonials

”It was an excellent opportunity to hear what the authorities industry, even sometimes what our competitors or other providers have to say about the topic.”

Alison Bascou, Sr. Regulatory Director at BD, France
"I think it's being an interesting event. Wherever there's discussion at top level, wherever there's respect. wherever there's an open forum, science can advance. It's very important to keep patient's well-being in mind and I think this forum allows that."

Jaime Uribe, CEO At PROBIOMED
“The strength of the biosimilar industry in our region is very encouraging. It seems to me this event is the propitious forum to share experiences and it is great.”

Tammy Boggiano Ayo, Process Development Director at CIM, Cuba
“It showed a broad picture, from a highly technical perspective up to a commercial viewpoint. It is not easy to get that in such a short period of time.”

Santiago Salguero, Executive Director at Pharmaceutical Association of Ecuador
“For companies like those I work for, i.e. suppliers to the pharmaceutical industry, this has been a great opportunity to see our clients’ perspective and above all to identify the major trends determining the future of biosimilars.”

Mauricio Roberto Hernández Morales, Key Account and Business Developer Manager at BD Mexico